RecruitingNCT06096688

Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction

Discovering New Targets for Hereditary and Sporadic Colorectal and Endometrial Cancer Risk Reduction

Sponsor

Weill Medical College of Cornell University

Enrollment

1,120 participants

Start Date

May 29, 2019

Study Type

OBSERVATIONAL

Conditions

Colorectal, Cancer Endometrial Cancer Hereditary Cancer Syndromes

Summary

The primary aim of this study is to collect and store data, tissue, and personal and family histories from patients being screened for colorectal cancer and/or endometrial cancer at NYPH and WCM for routine clinical care and to make these available for future use for molecular and mechanistic studies.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting tissue and biological samples from patients undergoing procedures related to colorectal cancer, endometrial cancer, or hereditary cancer syndromes (like Lynch syndrome). The goal is to discover new biological targets that could be used for earlier detection or prevention of these cancers. **You may be eligible if...** - You are 18 or older - You are having an endoscopy (colonoscopy, sigmoidoscopy, or upper GI scope) or uterine procedure at Weill-Cornell Medicine - OR you have been diagnosed with a hereditary cancer syndrome - OR you have colorectal or endometrial cancer and are being treated at Weill-Cornell Medicine - OR you are undergoing routine average-risk cancer screening **You may NOT be eligible if...** - You are under 18 years old - You are unable or unwilling to give informed consent - You are not having a qualifying procedure or diagnosis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.